Daniel Lenihan is a Cardiology physician affiliated with Saint Francis Medical Center. OpenAlex indexes 446 publications with 25,117 citations (h-index 63); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Advanced Heart Failure and Transplant Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
211 Saint Francis Dr Ste 15
Cape Girardeau, MO 637035049
Telephone
573-331-3333Provider last certified this registry record 19 Jun 2023.
Clinical trials
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Sponsor: Abbott Medical Devices
- Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
Sponsor: Vanderbilt University
- Natrecor in Pulmonary Hypertension
Sponsor: M.D. Anderson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BridgeBio Pharma, Inc.Program year202521 payments$28,058openpaymentsdata.cms.gov ↗
- CVRx, Inc.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.7%Beta blocker17.4%Carvedilol75%Metoprolol Succinate16%Metoprolol Tartrate10%Part D≥140 patientsLoop diuretic13.5%Furosemide83%Torsemide12%Bumetanide4%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
11.8%SGLT2 inhibitor10.6%Jardiance67%Farxiga33%Part D≥69 patientsPotassium supplement0.7%Potassium Chloride100%Part D<11 patients+ 1 more class in this area
Blood & clotting
10.2%Factor Xa inhibitor8.1%Eliquis72%Xarelto28%Part D≥56 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”